|
News For MDT;COV;INTC;BSX;VRTX;JNJ From The Last 14 Days Check below for free stories on MDT;COV;INTC;BSX;VRTX;JNJ the last two weeks. |
|
|
| May 20, 2013 |
| 09:41 EDT |  | BSX, MDT | Supreme Court agrees to hear Medtronic-Boston Scientific patent case
Reported by SCOTUSblog live blog of court orders and opinions. |
|
| 08:10 EDT |  | INTC | Intel management to meet with Deutsche Bank
Meeting to be held in Stockholm on May 20 hosted by Deutsche Bank. |
|
| 08:05 EDT | | COV | Covidien receives FDA 510(k) clearance for Nellcor pulse oximetry motion claims
 Subscribe for More Information |
|
| 07:32 EDT | | INTC | Society for Information Display / IHS to host a conference
Display Week 2013 is being held in Vancouver, British Columbia on May 19-24. |
|
| 07:32 EDT | | INTC | Society for Information Display / IHS to host a conference
Subscribe for More Information |
|
| 07:11 EDT | | MDT | Medtronic receives CE mark for 'export advance' aspiration catheter
Subscribe for More Information |
|
| May 19, 2013 |
| 18:59 EDT |  | INTC | Cisco looks the best out of tech comeback stocks, Barron's says
Cisco (CSCO), Intel (INTC), and Microsoft (MSFT) stocks have jumped this month, however, Intel and Microsoft's revenue growth declined, due to their reliance on the PC market, providing Cisco with an opportunity to pull ahead in the technology sector, Barron's contends in its Technology Trader column. Cisco looks moderately priced, the paper adds. Reference Link |
|
| May 17, 2013 |
| 06:19 EDT | | JNJ | J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports
Subscribe for More Information |
|
| May 16, 2013 |
| 16:13 EDT | | BSX | Vascular Solutions files patent infringement complaint against Boston Scientific
Vascular Solutions (VASC) announced that it has filed a patent infringement complaint in the U.S. District Court for the District of Minnesota against Boston Scientific Corporation (BSX). The complaint alleges that Boston Scientific has infringed three patents owned by Vascular Solutions concerning rapid exchange guide extension technology by manufacturing and selling its Guidezilla guide extension catheter which received 510(k) clearance in March. Vascular Solutions is seeking an injunction against Boston Scientific prohibiting the manufacture and sale of its Guidezilla catheter as well as damages for lost profits and legal costs. |
|
| 13:40 EDT | | INTC | Intel CFO Smith says staying with the company, CNBC reports
Subscribe for More Information |
| |
| 13:32 EDT |  | MDT | Medtronic volatility flat into Q4 and outlook
Subscribe for More Information |
|
| 10:03 EDT |  | MDT | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 07:51 EDT |  | BSX | Boston Scientific price target raised to $12 from $9 at JMP Securities
JMP Securities increased its price target on Boston Scientific as the firm believes after speaking with experts that S-ICD devices can be used in 50% of de novo implant cases, up from its previous estimate of 30%. The firm's FY13 and FY14 earnings estimates for the company are well above consensus levels and it reiterates an Outperform rating on the shares. |
|
| 07:28 EDT | | COV, BSX | I/O Central to host a conference
Subscribe for More Information |
|
| 06:32 EDT | | MDT | Medtronic downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information |
|
| 05:59 EDT | | INTC | High tech firms involved in immigration battle, WSJ reports
Subscribe for More Information |
|
| May 15, 2013 |
| 16:51 EDT | | JNJ | FDA approves Simponi to treat ulcerative colitis
Subscribe for More Information |
|
| May 14, 2013 |
| 15:33 EDT | | BSX | Boston Scientific has a conference call hosted by JPMorgan
JPMorgan Analyst Weinstein will host a conference call with CEO Mike Mahoney on May 17 at 11 am. |
|
| May 13, 2013 |
| 07:30 EDT | | INTC | TechConnect to host a summit
2013 National Innovation Summit is being held in Washington, D.C. on May 12-16. |
|
| May 10, 2013 |
| 15:49 EDT | | MDT | Medtronic defibrillators demonstrate success of shock avoidance
Subscribe for More Information |
| |
| 14:02 EDT | | VRTX | Vertex to benefit from Welsh government decision, says Wells Fargo
Subscribe for More Information |
|
| 11:48 EDT | | JNJ | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information |
|
| 10:00 EDT |  | BSX | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 09:03 EDT | | BSX | Boston Scientific receives CEO Mark approval for Rhythmia mapping system
Subscribe for More Information |
|
| 06:16 EDT | | COV, JNJ | Obesity surgery booming in India, Bloomberg reports
Subscribe for More Information |
|
| 05:46 EDT | | BSX | Boston Scientific upgraded to Outperform from Market Perform at Wells Fargo
Subscribe for More Information |
|
| May 9, 2013 |
| 17:09 EDT | | JNJ | Johnson & Johnson deal to settle sales practices probe stalls, WSJ reports
Johnson & Johnson's $2.2B settlement with the Justice Department related to its promotion of certain drugs is on hold as the company is looking to avoid language in the agreement that could make it vulnerable to private lawsuits, reports The Wall Street Journal, citing people familiar with the talks. Reference Link |
|
| 14:30 EDT | | INTC | Options Update; May 9, 2013
Subscribe for More Information |
|
| 12:04 EDT | | BSX | Boston Scientific says data show Watchman device superior to warfarin
Boston Scientific reports that the four-year follow-up data from the PROTECT AF clinical trial demonstrated the WATCHMAN Left Atrial Appendage Closure device was statistically superior to warfarin for preventing cardiovascular death, all-cause stroke and systemic embolization. The data demonstrated significant reductions in both cardiovascular and all death compared to warfarin. The data were presented today as a late-breaking clinical trial at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions. |
|
| 09:51 EDT | | JNJ | J&J unit says first patient enrolled in reMARQable study
Subscribe for More Information |
| |
| 09:27 EDT | | BSX | Leerink's medical devices analyst holds a conference call
Subscribe for More Information |
|
| May 8, 2013 |
| 07:49 EDT | | INTC | BofA/Merrill's semiconductor analyst holds an analyst/industry conference call
Subscribe for More Information |
|
| 07:38 EDT | | BSX, COV, MDT, JNJ | BofA/Merrill's medical tech analyst hold an analyst/industry conference call
Subscribe for More Information |
|
| May 7, 2013 |
| 08:05 EDT | | INTC | Stable capactiy, rising demand to drive up memory prices, FT says
After years of price competition and industry consolidation, analysts do not expect any new memory chip capacity to be introduced this year, which coupled with rising demand driven by smartphone growth is set to feed through into prices, Financial Times said. Samsung Electronics (SSNLF), SK Hynix and Micron (MU) now hold more than 90% of the D-Ram market and almost 100% of the Nand market is divided between those three and Intel (INTC), Toshiba (TOSBF) and SanDisk (SNDK), the report noted, citing analysts at Bernstein. Reference Link |
|
| 07:24 EDT | | COV | Mizuho Securities to host a conference
Subscribe for More Information |
|
| May 6, 2013 |
| 14:06 EDT | | INTC | Intel announces new mobile chip design, AllThingsD says
Intel revealed its new "Silvermont" low-power chips on Monday, with the new chip design focused on powering smartphone and tablet devices, reports AllThingsD. Reference Link |
|
| 11:29 EDT | | JNJ | J&J cosmetics license revoked at Mumbai plant, Reuters says
Subscribe for More Information |
|
| 10:23 EDT |  | INTC | Intel initiated with a Buy at Topeka
Subscribe for More Information |
|
| 10:05 EDT | | INTC | Intel shares upgraded despite out of favor PC market
Subscribe for More Information |
|
| 10:04 EDT | | INTC | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
| |
| 09:19 EDT | | MDT | Medtronic receives FDA approval for newest cardiac devices
Medtronic announced FDA approval and U.S. launch of its newest cardiac devices: the Viva portfolio of cardiac resynchronization therapy with defibrillation, or CRT-D, devices, and the Evera portfolio of implantable cardioverter-defibrillators. |
|
| 08:06 EDT | | BSX | Boston Scientific completes first-in-human clinical trial of IntellaTip Mifi XP
Boston Scientific completed a first-in-human clinical trial utilizing the IntellaTip MiFi XP Ablation Catheter for the treatment of type 1 atrial flutter, an arrhythmia originating in the right atrium of the heart that affects nearly one million people in the United States. This single center feasibility trial enrolled 10 patients and was led by Prash Sanders, MBBS, PhD, FHRS, director of the Centre for Heart Rhythm Disorders at the University of Adelaide and the Royal Adelaide Hospital. Patients with type 1 atrial flutter may exhibit symptoms that include palpitations, shortness of breath, fatigue, lightheadedness and fainting. Catheter ablation, a procedure in which localized electrical energy is delivered into the heart tissue aimed at restoring the continuous normal rhythm, has become a first-line treatment approach for patients with recurrent type 1 atrial flutter and demonstrates more successful short- and long-term outcomes compared to anti-arrhythmic drug therapy. |
|
| 07:24 EDT | | JNJ | Drug companies attempt to make painkillers that can't be abused, WSJ reports
Subscribe for More Information |
|
| 07:18 EDT | | COV | American Congress of Obstetrics and Gynecology to hold annual meeting
Subscribe for More Information |
|
| 05:57 EDT | | COV | Covidien to host conference call
Subscribe for More Information |
|
| 05:52 EDT | | INTC | Intel upgraded to Outperform from Sector Perform at RBC Capital
Subscribe for More Information |
|
| 05:17 EDT | | INTC | McAfee to acquire Stonesoft for $389M in cash
McAfee, a wholly owned subsidiary of Intel, announced the execution of a definitive agreement to initiate a conditional tender offer for the acquisition of Stonesoft Oyj for an aggregate equity value of approximately $389M in cash. The pending acquisition is expected to extend the success of McAfee's security connected strategy. |
|
|
|
|
|
